Bogdan Iorga, Ph.D.
Affiliations: | 1998-2002 | École Polytechnique, Palaiseau, Île-de-France, France | |
2002- | ICSN | CNRS, Paris, Île-de-France, France |
Area:
Computational chemistry, Drug design, BioinformaticsGoogle:
"Bogdan Iorga"Mean distance: (not calculated yet)
Parents
Sign in to add mentorPhilippe Savignac | grad student | 1998-2001 | École Polytechnique | |
(Synthèse d'alpha-monohalogénophosphonates par halogénation électrophile) | ||||
Jean-Marc Campagne | post-doc | 2002-2003 | CNRS |
Children
Sign in to add traineeMarie Varin | grad student | 2004-2007 | Université Paris-Sud |
François Martz | grad student | 2011-2014 | Université Paris-Sud |
Maria-Laura-Belén Dabos | grad student | 2015-2018 | Université Paris-Saclay |
Agustín Zavala | grad student | 2015-2018 | Université Paris-Saclay |
Eddy Elisée | grad student | 2016-2019 | Université Paris-Saclay |
Guillaume Bernadat | post-doc | 2009-2010 | CNRS |
Najette Amara | post-doc | 2011-2012 | CNRS |
Georgiana Surpateanu | post-doc | 2009-2013 | CNRS |
Claire Colas | post-doc | 2011-2013 | CNRS |
Cheickna Cissé | post-doc | 2012-2013 | CNRS |
Edithe Selwa | post-doc | 2013-2018 | CNRS |
Nawel Mele | post-doc | 2018-2019 | CNRS |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Gonzalez C, Oueslati S, Rima M, et al. (2024) Molecular, Genetic, and Biochemical Characterization of OXA-484 Carbapenemase, a Difficult-to-Detect R214G Variant of OXA-181. Microorganisms. 12 |
Rima M, Oueslati S, Cotelon G, et al. (2024) Role of amino acid 159 in carbapenem and temocillin hydrolysis of OXA-933, a novel OXA-48 variant. Antimicrobial Agents and Chemotherapy. e0018024 |
Oliver A, Rojo-Molinero E, Arca-Suarez J, et al. (2023) Pseudomonas aeruginosa antimicrobial susceptibility profiles, resistance mechanisms and international clonal lineages: update from ESGARS-ESCMID/ISARPAE Group. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases |
Denakpo E, Naas T, Iorga BI. (2023) An updated patent review of metallo-β-lactamase inhibitors (2020-2023). Expert Opinion On Therapeutic Patents. 33: 523-538 |
Gaillot S, Oueslati S, Vuillemenot JB, et al. (2023) Genomic characterization of an NDM-9-producing clinical isolate and role of Glu152Lys substitution in the enhanced cefiderocol hydrolysis of NDM-9. Frontiers in Microbiology. 14: 1253160 |
Dabos L, Raczynska JE, Bogaerts P, et al. (2023) Structural and Biochemical Features of OXA-517: a Carbapenem and Expanded-Spectrum Cephalosporin Hydrolyzing OXA-48 Variant. Antimicrobial Agents and Chemotherapy. e0109522 |
Dahdouh E, Allander L, Falgenhauer L, et al. (2022) Computational Modeling and Design of New Inhibitors of Carbapenemases: A Discussion from the EPIC Alliance Network. International Journal of Molecular Sciences. 23 |
Muntean MM, Muntean AA, Guerin F, et al. (2022) Optimization of the rapid carbapenem inactivation method for use with AmpC hyperproducers-authors' response. The Journal of Antimicrobial Chemotherapy |
Jousset AB, Oueslati S, Emeraud C, et al. (2021) KPC-39-Mediated Resistance to Ceftazidime-Avibactam in a Klebsiella pneumoniae ST307 Clinical Isolate. Antimicrobial Agents and Chemotherapy. 65: e0116021 |
de Barsy M, Mercuri PS, Oueslati S, et al. (2021) Detection and characterization of VIM-52, a new variant of VIM-1 from clinical isolate. Antimicrobial Agents and Chemotherapy. AAC0266020 |